NMTC · NASDAQ
Neuroone Medical Technologies (NMTC) Stock Price & Fundamentals
Neuroone Medical Technologies (NMTC) closed at $270.53 on Oct 9, 2026, down 0.54% from the previous close of $272.00.
Share price, past year
1Y +17.66%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $270.53 |
| Sep 30, 2026 | $274.89 |
| Aug 31, 2026 | $277.55 |
| Jul 31, 2026 | $266.09 |
| Jun 30, 2026 | $252.27 |
| May 29, 2026 | $256.36 |
| Apr 30, 2026 | $240.85 |
| Mar 31, 2026 | $242.57 |
| Feb 27, 2026 | $239.70 |
| Jan 30, 2026 | $243.99 |
| Dec 31, 2025 | $235.38 |
| Nov 28, 2025 | $229.00 |
| Oct 31, 2025 | $222.60 |
Key statistics
- Market cap
- $2.35B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.11
- Revenue (TTM)
- $9.47M
- Net income (TTM)
- −$7.45M
- Shares outstanding
- 8.7M
- Dividend yield
- —
- 52-week range
- $217.21 – $279.74
Neuroone Medical Technologies's market cap is $2.35B, based on a share price of $270.53 and 8.7M shares outstanding as of Jun 30, 2026.
Financials
Neuroone Medical Technologies reported revenue of $9.10M for fiscal 2025, up 163.47% from fiscal 2024.
Neuroone Medical Technologies reported a net loss of $3.61M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Sep 30, 2025 | $9.10M | +163.5% | −$3.61M | −39.6% | −$0.09 | −$2.92M |
| FY2024ended Sep 30, 2024 | $3.45M | +76.9% | −$12.32M | −356.7% | −$0.46 | −$11.13M |
| FY2023ended Sep 30, 2023 | $1.95M | +1,040.7% | −$11.86M | −607.4% | −$0.65 | −$13.27M |
| FY2022ended Sep 30, 2022 | $171.17K | −3.9% | −$10.00M | −5,842.0% | −$0.63 | −$7.79M |
| FY2021ended Sep 30, 2021 | $178.15K | — | −$9.95M | −5,584.3% | −$0.93 | −$8.67M |
| FY2016ended Dec 31, 2016 | $0.00 | — | −$47.78K | — | −$0.01 | — |
| FY2015ended Dec 31, 2015 | $0.00 | −100.0% | −$62.86K | — | −$0.01 | — |
| FY2014ended Dec 31, 2014 | $773.00 | −38.1% | −$36.24K | −4,688.8% | −$0.01 | — |
| FY2013ended Dec 31, 2013 | $1.25K | +35.6% | — | — | — | — |
| FY2012ended Dec 31, 2012 | $921.00 | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q3 FY2026ended Jun 30, 2026 | $1.97M | −$2.01M | −$0.28 |
| Q2 FY2026ended Mar 31, 2026 | $1.86M | −$2.38M | −$0.28 |
| Q1 FY2026ended Dec 31, 2025 | $2.89M | −$1.44M | −$0.03 |
| Q4 FY2025ended Sep 30, 2025 | $2.74M | −$1.62M | $0.48 |
| Q3 FY2025ended Jun 30, 2025 | $1.70M | −$1.50M | −$0.19 |
| Q2 FY2025ended Mar 31, 2025 | $1.39M | −$2.27M | −$0.44 |
| Q1 FY2025ended Dec 31, 2024 | $3.27M | $1.79M | $0.06 |
| Q4 FY2024ended Sep 30, 2024 | $272.28K | −$3.35M | −$0.11 |
Company profile
- Name
- NEUROONE MEDICAL TECHNOLOGIES Corp
- Ticker
- NMTC
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 7599 Anagram Dr, Eden Prairie, MN 55344
- Incorporated in
- DE
- Fiscal year ends
- September
- SEC CIK
- 0001500198
Recent SEC filings
- Oct 5, 2026
- Aug 27, 2026
- Aug 13, 2026
- Aug 13, 2026
- Jun 12, 2026
- Jun 12, 2026
- May 22, 2026
- May 12, 2026
Frequently asked questions
What is Neuroone Medical Technologies's stock price?
Neuroone Medical Technologies (NMTC) closed at $270.53 on Oct 9, 2026, down 0.54% from the previous close of $272.00.
What is Neuroone Medical Technologies's market cap?
Neuroone Medical Technologies's market cap is $2.35B, based on a share price of $270.53 and 8.7M shares outstanding as of Jun 30, 2026.
How much revenue does Neuroone Medical Technologies make?
Neuroone Medical Technologies reported revenue of $9.10M for fiscal 2025, up 163.47% from fiscal 2024.
Does Neuroone Medical Technologies pay a dividend?
Neuroone Medical Technologies's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from NEUROONE MEDICAL TECHNOLOGIES Corp's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures